Upgrade to SI Premium - Free Trial

Henry Schein (HSIC) Tops Q2 EPS by 3c, Revenues Beat; Increases FY18 EPS Outlook

August 6, 2018 7:04 AM

Henry Schein (NASDAQ: HSIC) reported Q2 EPS of $1.04, $0.03 better than the analyst estimate of $1.01. Revenue for the quarter came in at $3.33 billion versus the consensus estimate of $3.31 billion.

"Results for the second quarter reflect solid revenue growth in generally healthy end-markets, as well as our continued success in gaining market share in all of our business groups. We are in the early stages of executing on our new strategic plan for 2018 through 2020, yet we are already making solid strides in expanding our offering of innovative solutions and extending our value proposition for customers," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein.

Henry Schein, Inc. today is revising its 2018 non-GAAP diluted EPS guidance. At this time the Company is not able to provide estimates for the total impact of costs related to the Animal Health spin-off on full year 2018 financial results. Guidance is as follows:

GUIDANCE:

Henry Schein sees FY2018 EPS of $4.06-$4.14, versus the consensus of $4.10.

For earnings history and earnings-related data on Henry Schein (HSIC) click here.

Categories

Earnings Guidance Hot Guidance Management Comments

Next Articles